Article Versions Notes

Di Martino MT, Arbitrio M, Fonsi M, Erratico CA, Scionti F, Caracciolo D, Tagliaferri P, Tassone P. Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221. Cancers. 2020; 12(1):27. https://doi.org/10.3390/cancers12010027

Di Martino, Maria Teresa, Mariamena Arbitrio, Massimiliano Fonsi, Claudio Alberto Erratico, Francesca Scionti, Daniele Caracciolo, Pierosandro Tagliaferri, and Pierfrancesco Tassone. 2020. "Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221" Cancers 12, no. 1: 27. https://doi.org/10.3390/cancers12010027

Di Martino, M. T., Arbitrio, M., Fonsi, M., Erratico, C. A., Scionti, F., Caracciolo, D., Tagliaferri, P., & Tassone, P. (2020). Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221. Cancers, 12(1), 27. https://doi.org/10.3390/cancers12010027